The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%.

Clarity, along with most Aussie biotech, has been caught in a double whirlwind: a sharp sell-off in US healthcare stocks and ...

The report, not made public, was commissioned by the main US pharmaceutical lobby, the Pharmaceutical Research and ...

Shares of biotech companies involved in the development of monoclonal antibody cancer therapies were moving all over the ...

Eli Lilly alleges Willow falsely claims its products are safe, effective and superior to its FDA-approved tirzepatide medicines, sold under Lilly's brand names: Mounjaro, which treats diabetes, and ...

With the potential for pharmaceutical import tariffs spurring a rush of life sciences investments in the U.S., AbbVie is joining the trend with plans to spend billions in the country over the next | ...

“The co-founders took a chance on the business idea for Q1 Scientific because outsourcing storage wasn’t really a thing at ...

Dataworks has worked to help clients to drive improvements and ensure compliance by moving from paper-based to electronic ...

Industries that range from pharmaceuticals to tech, and even fashion, have signaled they could build more capacity in the U.S ...

Pharmaceutical companies in China are reporting that they have been able to import some drugs over the past week with tariff ...

Drugmakers breathed a sigh of relief Wednesday after President Trump didn’t announce pharmaceutical tariffs. Plus, language in the executive order indicated medicines were exempted from the ...

Major drugmakers were a standout on a tumultuous day of corporate earnings on Thursday, beating expectations even as they ...